Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

620 public trials 220 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

NCT07020117

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +20 more
Locations
  • City of Hope Duarte, California, United States
  • Hoag Memorial Hospital Presbyterian Irvine, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Advent Health Medical Group Radiation Oncology at Central Florida Orlando, Florida, United States
View all 13 locations
View Trial Details
Recruiting

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

NCT06841354

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • USA Mitchell Cancer Institute ( Site 0090) Mobile, Alabama, United States
  • Ironwood Cancer & Research Centers ( Site 0036) Chandler, Arizona, United States
  • City of Hope ( Site 0097) Duarte, California, United States
  • City of Hope Lennar Foundation Cancer Center ( Site 0099) Irvine, California, United States
View all 274 locations
View Trial Details
Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT04981119

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
View all 16 locations
View Trial Details
Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

NCT06393374

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Infirmary Cancer Care ( Site 0001) Mobile, Alabama, United States
  • Ironwood Cancer & Research Centers-Research ( Site 0054) Chandler, Arizona, United States
  • MemorialCare Orange Coast Medical Center ( Site 9501) Fountain Valley, California, United States
  • Scripps Cancer Center ( Site 0052) La Jolla, California, United States
View all 310 locations
View Trial Details
Recruiting

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

NCT05837767

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +65 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers

NCT07545122

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +16 more
Locations
  • Tasman Oncology Research Gold Coast, Queensland, Australia
  • Calvary Mater Hospital Newcastle Newcastle, Queensland, Australia
  • Linear Clinical Research Perth, Western Australia, Australia
  • Sydney Adventist Hospital Wahroonga, New South Wales, Australia
View Trial Details

Related conditions